Author, Subjects, Keywords

Cited Author

 

 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Peripartum Cardiomyopathy: an Overview

Wan Azman W.A., and Hazal H.K., (2005) Peripartum Cardiomyopathy: an Overview. Journal of the University of Malaya Medical Centre (JUMMEC), 8 (1). pp. 18-22. ISSN 1823-7339

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
94Kb

Official URL: http://jummec.um.edu.my

Affiliations

University of Malaya. Faculty of Medicine. Division of Cardiology
University of Malaya. Faculty of Medicine. Division of Cardiology

Abstract

Peripartum cardiomyopathy (PPCM) is a life-threatening cardiomyopathy of an unknown cause that occurs in the peripartum period in previously healthy women and this article discusses the challenges that lie in diagnosing and managing this rare yet lethal disease.

Item Type:Journal
Keywords:Peripartum, cardiomyopathy, pregnancy, cardiac failure, Women
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:6363

1. Demakis JG, Rahimtoola SLI, Sutton, GC et al. Natural course of peripartum cardiomyopathy. Circulation 1971; 44:1058-61.

2. Seftel H, Susser M. Maternity and myocardial failure in African women. Br Heart J 1961; 28:157-67.

3. Manolio TA, Baughman KL, Rodeheffer R, et al. Prevalence and etiology of idiopathic cardiomyopathy (summary of a National Heart, Lung, and Blood Institute Workshop).Am J Cardiol. 1992; 69:1458-1466.

4. Ventura SJ, Peters KD,Martin JA, et al. Births and deaths: United States, 1996.Mon Vital Stat Rep. 1997; 46(1 suppl2):1-40.

5. Familial occurrence of postpartal heart failure. Arch Intern Med. 1962; 111:163-166.

6. Massad LS, Reiss CK,Mutch DG, et al. Family peripartum cardiomyopathy after molar pregnancy.Obstet Gynecol. 1993; 81:886-888.

7. Pearl W. Familial occurrence of peripartum cardiomyopathy. Am Heart J. 1995; 129:421-422.

8. Melvin KR, Richardson PJ, Olsen EG, et al. Peripartum cardiomyopathy due to myocarditis. N Engl J Med. 1982;307:731-734.

9. Midei MG, DeMent SH, Feldman AM, et al. Peripartum myocarditis and cardiomyopathy. Circulation. 1990; 81: 922-928.

10. Farber PA, Glasgow LA. Viral myocarditis during pregnancy: encephalomyocarditis virus infection in mice. Am Heart J. 1970; 80:96-102.

11. Artlett CM, Jimenez SA, Smith JB. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med. 1998; 338:1186-1191.

12. Nelson JL, Bianchi DW, Ober C, et al. Microchimerism and HLA compatible relationships of pregnancy in scleroderma. Lancet. 1998; 351:559-562.

13. Geva T, Mauer MB, Striker L, et al. Effects of physiologic load of pregnancy on left ventricular contractility and remodeling.Am Heart J. 1997; 133:53-59.

14. Mone SM, Sanders SP,Colan SD.Control mechanisms for physiological hypertrophy of pregnancy. Circulation. 1996; 94:667-672.

15. Witlin AG, Mable WC, Sibai BM. Peripartum cardiomyopathy: An ominous diagnosis.Am J Obstet Gynecol. 1997; 176:182-188.

16. Sliwa K, Skudicky D, Bergemann A, et al. Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO- 1. J Am Coll Cardiol. 2000; 35(3):701-705.

17. Coulson CC, Thorp JM Jr, Mayer DC, et al. Central haemodynamic effects of recombinant human relaxin in the isolated, perfused rat heart model. Obstet Gynecol. 1996; 87:610-612.

18. Brito O, de Lacerda AP, Freitas P, et al. Incessant atrial tachycardia and peripartum cardiomyopathy – a therapeutic challenge. Rev Port Cardiol. 1997; 16(2):157-163.

19. Janssens U,Klues HG,Hanrath P. Successful thrombolysis of right atrial and ventricle thrombi in a patient with peripartum cardiomyopathy and extensive thromboembolism. Heart. 1997; 78(5):515-516.

20. Melndoe AK, Hammond EJ, Babington PC. Peripartum cardiomyopathy presenting as a cardiac arrest at induction of anaesthesia for emergency Caesarian section.Br J Anaesth. 1995; 75(1):97-101.

21. O’Connel JB, Costanzo-Nordin MR, Subramaniam R, et al. Peripartum cardiomyopathy: Clinical, haemodynamic, histologic and prognostic characteristics. J Am Coll Cardiol. 1986; 8:52-56.

22. Van Haevan KH, Kitsis RN, Katz SD. Peripartum versus idiopathic dilated cardiomyopathy in young women – a comparison of clinical, pathological and prognostic features. Int J Cardiol. 1993; 40:57.

23. CONSENSUS Trial Study Group. Effects of Enalapril on mortality in severe congestive cardiac failure. N Engl J Med. 1987; 316:1429-1435.

24. Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomized trial – the losartan heart failure survival study (ELITE II). Lancet. 2000; 355(9215):1582-1587.

25. Cohn JN, Tognoni G, Valsartan Heart Failure Trial (Val-HeFT) nvestigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 2001; 345(23):1667-1675.

26. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydraline and isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991; 325:303-310.

27. Packer M,Gheorghia de M,Young JB, et al.Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. N Engl J Med. 1993; 329:1-7.

28. CIBIS Investigators and Committees.A randomized trial of beta-blockade in heart failure: The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation. 1994; 90: 1765-1773.

29. MERIT-HF Study Group. Effect of Metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERITHF).Lancet. 1999; 353:2001-2007.

30. Packer M, Coats AJ, Fowler MB, COPERNICUS Study Group. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001; 44(22): 1651-1658.

31. Packer M, O’Connor CM, Ghali JK, et al for the PRAISE Study Group. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med.1996; 335:1107-1114.

32. Midei MG, Dement SH, Feldmon AM, et al. Peripartum myocarditis and cardiomyopathy. Circulation. 1990; 81:922-928.

33. Bozkurt B,Villaneuva FS, Holubkov R, et al. Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol. 1999; 34:177-180.

34. Sliwa K, Skudicky D, Candy G, et al. The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy. Eur J Heart Fail. 2002; 4(3):305-309.

35. Keogh A, Macdonald P, Spratt P, et al. Outcome in peripartum cardiomyopathy after heart transplantation. Heart Lung Transplant. 1994; 13:202-207.

36. Sutton MS,Cole P, Plappert M, et al. Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy.Am Heart J. 1991; 121:1776-1778.

37. Carvalho A, Brandao A, Martinez EE, et al. Prognosis is peripartum cardiomyopathy. Am J Cardiol. 1989; 64:540-542.

38. Felker GM, Jaeger CJ, Klodas E, et al. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J. 2000 Nov; 140(5):785-91.

39. Sutton MS,Cole P, Plappert M, et al. Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy.Am Heart J. 1991; 121: 1776-1778.

40. Lampert M, Weinert L, Hibbard J, et al. Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function.Am J Obstet Gynecol. 1997; 176(1 pt 1):189-195.

41. Ceci O, Berardesca C, Caradonna F, et al. Recurrent peripartum cardiomyopathy. Eur J Obstet Gynecol Reprod Biol. 1998; 76:29-30.

Repository Staff Only: item control page